Suppliers in Racine, WI
15 Medicare Suppliers found. Showing 1 - 15
 |
Cvs Pharmacy # 10533 Durable Medical Equipment & Medical Supplies Location: 3915 Durand Ave, Racine, Wisconsin 53405 Phone: (262) 554-0035 |
Walgreens #7437 Durable Medical Equipment & Medical Supplies Location: 3825 Durand Ave, Racine, Wisconsin 53405 Phone: (262) 554-8686 |
Walgreens #9363 Durable Medical Equipment & Medical Supplies Location: 1920 Douglas Ave, Racine, Wisconsin 53402 Phone: (262) 633-4948 |
Aurora Pharmacy Durable Medical Equipment & Medical Supplies Location: 8400 Washington Avenue, Racine, Wisconsin 53406 Phone: (262) 884-4030 |
Walgreens #6243 Durable Medical Equipment & Medical Supplies Location: 5005 Douglas Ave, Racine, Wisconsin 53402 Phone: (262) 639-9141 |
|
Walgreens #2927 Medicare Supplier Location: 4810 Washington Ave, Racine, Wisconsin 53406 Phone: (262) 635-0181 |
Walgreens #3022 Medicare Supplier Location: 819 N Memorial Dr, Racine, Wisconsin 53404 Phone: (262) 637-4900 |
Racine Hometown Pharmacy Durable Medical Equipment & Medical Supplies Location: 3900 Erie St, Racine, Wisconsin 53402 Phone: (262) 639-1611 |
Metz Medical Inc. Medicare Supplier Location: 1801 S. Green Bay Rd, Racine, Wisconsin 53406 Phone: (262) 654-4000 |
Wisconsin Vision Inc Medicare Supplier Location: 3905 Douglas Ave, Racine, Wisconsin 53402 Phone: (262) 639-5360 |
Wisconsin Vision Inc Medicare Supplier Location: 6035 Durand Ave, Racine, Wisconsin 53406 Phone: (262) 554-8600 |
Elliott Vision Center Medicare Supplier Location: 2722 Old Mill Dr, Racine, Wisconsin 53405 Phone: (262) 632-2020 |
Lenscrafters #781 Eyewear Supplier (Equipment, not the service) Location: 5778 Durand Ave, Racine, Wisconsin 53406 Phone: (262) 554-6676 |
News Archive
Researchers use fruit fly to develop a novel disease model for Pitt-Hopkins syndrome
The researchers from the TalTech molecular neurobiology laboratory headed by professor Tõnis Timmusk used the fruit fly, Drosophila melanogaster to develop a novel disease model for Pitt-Hopkins syndrome (PTHS).
FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Levetiracetam Tablets, 250 mg, 500 mg, 750 mg and 1000 mg ("levetiracetam tablets").
Type 1 diabetes linked to gut microbiome and genetic factors
A new study has revealed that the gut microbiome of children with a high genetic risk of developing type 1 diabetes is markedly different from those who have a low risk of the condition.
Scientists explore chili pepper's effect to develop new drug candidate for pain
Biting into a chili pepper causes a burning spiciness that is irresistible to some, but intolerable to others. Scientists exploring the chili pepper's effect are using their findings to develop a new drug candidate for many kinds of pain, which can be caused by inflammation or other problems.
Investigators identify seven new genetic regions associated with AMD
An international group of investigators has identified seven new genetic regions associated with age-related macular degeneration (AMD), a common cause of blindness in older individuals. The findings, reported online March 3 in Nature Genetics, could point to new biological pathways and therapeutic targets for AMD.
› Verified 1 days ago